Guidelines Developed for Pain Management in Cancer Survivors

This article originally appeared here.
Share this content:
Guidelines Developed for Pain Management in Cancer Survivors
Guidelines Developed for Pain Management in Cancer Survivors

TUESDAY, July 26, 2016 (HealthDay News) -- Guidelines have been developed for chronic pain management in adult cancer survivors. The American Society of Clinical Oncology Clinical Practice Guideline was published online July 25 in the Journal of Clinical Oncology.

Judith A. Paice, Ph.D., R.N., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues conducted a systematic literature search of studies examining chronic pain management in cancer survivors to provide evidence-based guidelines on optimum management. Sixty-three studies were included as the evidentiary basis for the recommendations.

The researchers note that, at each encounter, clinicians should screen for pain. In any patient who reports new-onset pain, recurrent disease, secondary malignancy, or late-onset treatment effects should be assessed, treated, and monitored. In patients with complex needs, clinicians should assess the need for other health professionals to provide comprehensive pain management care. To relieve chronic pain and/or improve function, systemic non-opioid analgesics and adjuvant analgesics may be prescribed. A trial of opioids may be prescribed in selected patients who do not respond to more conservative management; risks of adverse effects of opioids should be assessed. Clinicians should understand concepts such as tolerance, dependence, abuse, and addiction as they relate to opioid use.

"Numerous gaps in existing evidence have been identified and highlighted in this guideline," the authors write. "Comprehensive assessment, including the impact of pain on function and quality of life, is warranted for all survivors."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Dupixent to Treat Eczema

FDA Approves Dupixent to Treat Eczema

Active ingredient binds to protein (interleukin-4 receptor alpha subunit) that causes inflammation

Arm, Hand Function Restored in Tetraplegic Patient

Arm, Hand Function Restored in Tetraplegic Patient

Researchers utilized functional electric stimulation + intracortical brain-computer interface system

Total Knee Replacement Typically Has Minimal Impact on QoL

Total Knee Replacement Typically Has Minimal Impact on ...

Cost-effectiveness of the procedure could increase if restricted to more severely affected patients

is free, fast, and customized just for you!

Already a member?

Sign In Now »